HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of TYB-2285 on dual phase bronchoconstriction and airway hypersensitivity in guinea-pigs actively sensitized with ovalbumin.

Abstract
The effect of a new anti-asthmatic drug, TYB-2285 (3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile), was investigated in ovalbumin-sensitized guinea-pigs. When guinea-pigs were pretreated with TYB-2285 (300 mg kg-1, p.o., single dose or consecutively for 7 days), the immediate asthmatic response was inhibited as demonstrated by diminished cyanosis, but not the bronchoconstriction. TYB-2285, given singly or consecutively, inhibited the appearance of late asthmatic response and the infiltration of inflammatory cells, such as eosinophils, into the airway. Additionally, airway hyper-responsiveness was also reversed by the single administration of TYB-2285. Luminol-dependent chemiluminescence of airway-infiltrated cells stimulated with A23187 was inhibited by TYB-2285 in a dose-dependent manner. The present study suggests that TYB-2285 inhibits late asthmatic response and airway hyperresponsiveness by inhibiting the accumulation of eosinophils and other inflammatory cells into the airway, and also by inhibiting the production of oxygen radicals from airway-infiltrated cells.
AuthorsM Muraki, Y Tohda, R Sugihara, Y Nagasaka, S Nakajima
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 46 Issue 11 Pg. 883-6 (Nov 1994) ISSN: 0022-3573 [Print] England
PMID7897592 (Publication Type: Journal Article)
Chemical References
  • Nitriles
  • 3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile
  • Calcimycin
  • Luminol
  • Histamine
  • Ovalbumin
Topics
  • Animals
  • Asthma (drug therapy)
  • Bronchoalveolar Lavage Fluid (cytology)
  • Calcimycin (pharmacology)
  • Dose-Response Relationship, Drug
  • Guinea Pigs
  • Histamine (pharmacology)
  • Luminescent Measurements
  • Luminol
  • Male
  • Nitriles (therapeutic use)
  • Ovalbumin (immunology)
  • Respiratory Function Tests
  • Respiratory Hypersensitivity (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: